Suppr超能文献

基于胱抑素 C 的方程在糖尿病患者肾小球滤过率估算中的性能:一项符合 PRISMA 原则的系统评价和荟萃分析。

Performance of Cystatin C-Based Equations for Estimation of Glomerular Filtration Rate in Diabetes Patients: A Prisma-Compliant Systematic Review and Meta-Analysis.

机构信息

Graduate Program in Medical Science: Endocrinology, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil.

Endocrine Division, HCPA, Porto Alegre, Brazil.

出版信息

Sci Rep. 2019 Feb 5;9(1):1418. doi: 10.1038/s41598-018-38286-9.

Abstract

The accuracy of estimated glomerular filtration rate (eGFR) equations in diabetes mellitus (DM) patients has been extensively questioned. We evaluated the performance of cystatin C-based equations alone or in combination with creatinine to estimate GFR in DM patients. A PRISMA-compliant systematic review was performed in the MEDLINE and Embase databases, with "diabetes mellitus" and "cystatin C" as search terms. Studies comparing cystatin C-based eGFR equations with measured GFR (mGFR) in DM patients were eligible. Accuracies P10, P15, P20, and P30 indicated the proportion of eGFR results within 10, 15, 20, and 30% of mGFR. Single-arm meta-analyses were conducted, and the Quality of Diagnostic Accuracy Studies-II tool (QUADAS-2) was applied. Twenty-three studies comprising 7065 participants were included, and 24 equations were analyzed in a broad range of GFRs. Meta-analyses were completed for 10 equations. The mean P30 accuracies of the equations ranged from 41% to 87%, with the highest values found with both CKD-EPI equations. Mean P10-P15 achieved 35% in the best scenario. A sensitivity analysis to evaluate different mGFR methods did not change results. In conclusion, cystatin C-based eGFR equations represent measured GFR fairly at best in DM patients, with high variability among the several proposed equations.

摘要

估算肾小球滤过率(eGFR)方程在糖尿病(DM)患者中的准确性受到广泛质疑。我们评估了胱抑素 C 为基础的方程单独或与肌酐联合应用于 DM 患者估计 GFR 的性能。我们在 MEDLINE 和 Embase 数据库中进行了符合 PRISMA 标准的系统评价,使用“糖尿病”和“胱抑素 C”作为检索词。符合条件的研究包括比较胱抑素 C 为基础的 eGFR 方程与 DM 患者测量肾小球滤过率(mGFR)的研究。P10、P15、P20 和 P30 准确性表示 eGFR 结果与 mGFR 相差 10%、15%、20%和 30%的比例。进行了单臂荟萃分析,并应用了诊断准确性研究的质量工具(QUADAS-2)。纳入了 23 项研究,共 7065 名参与者,分析了广泛范围内的 24 个方程。完成了 10 个方程的荟萃分析。方程的平均 P30 准确性范围从 41%到 87%,其中 CKD-EPI 方程的准确性最高。最佳情况下,平均 P10-P15 达到 35%。敏感性分析评估不同 mGFR 方法并未改变结果。总之,胱抑素 C 为基础的 eGFR 方程在 DM 患者中最多只能很好地代表测量的 GFR,并且几种建议的方程之间存在很大的差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5c2/6363744/cd9d05734a1d/41598_2018_38286_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验